open access

Vol 71, No 1 (2012)
ORIGINAL ARTICLES
Published online: 2012-04-19
Submitted: 2012-06-27
Get Citation

Transforming growth factor beta1/Smad signalling pathway of aortic disorders: histopathological and immunohistochemical studies

S.-M. Yuan
Folia Morphol 2012;71(1):31-38.

open access

Vol 71, No 1 (2012)
ORIGINAL ARTICLES
Published online: 2012-04-19
Submitted: 2012-06-27

Abstract

Background: The aim of the present study was to evaluate the expressions and biological functions of the TGF-Β1/Smad signalling pathway of aortic disorders by way of histopathological and immunohistochemical studies.
Material and methods: Aortic specimens of 20 patients with aortic dissection, 9 patients with aortic aneurysm, 9 patients with coronary artery disease, and 5 deceased healthy adults were collected. The samples were stained with haematoxylin -eosin, Masson’s trichrome, van Gieson, and alcian blue, and with immunohistochemical stainings to detect TGF-Β1, type I receptor (TΒRI), Smad2/3, Smad4, and Smad7.
Results: Masson’s trichrome and van Gieson stainings showed attenuated collagens in the aorta of the patients with aortic dissection and aortic aneurysm. TGF-Β1, TΒRI, and Smad2/3 mainly showed a cytoplasmic immunoreactivity in the aortic media, Smad4 immunoreactivity was predominantly located in the cytoplasm and/or the nucleus of the aortic media, and Smad7 immunoreactivity was present in the nucleus of the aortic media and intima. The TGF-Β1 signalling pathway proteins were similarly expressed in the aorta of aortic dissection and aortic aneurysm patients, while they were less pronounced in the aorta of coronary artery disease patients, and weak or negative in the aorta of healthy control individuals.
Conclusions: These observations support the notion that there is an association between the TGF-Β1/Smad pathway and the pathological events of the aorta. Dysregulation of the TGF-Β1/Smad pathway may predispose the pathologenesis of aortic disorders.

Abstract

Background: The aim of the present study was to evaluate the expressions and biological functions of the TGF-Β1/Smad signalling pathway of aortic disorders by way of histopathological and immunohistochemical studies.
Material and methods: Aortic specimens of 20 patients with aortic dissection, 9 patients with aortic aneurysm, 9 patients with coronary artery disease, and 5 deceased healthy adults were collected. The samples were stained with haematoxylin -eosin, Masson’s trichrome, van Gieson, and alcian blue, and with immunohistochemical stainings to detect TGF-Β1, type I receptor (TΒRI), Smad2/3, Smad4, and Smad7.
Results: Masson’s trichrome and van Gieson stainings showed attenuated collagens in the aorta of the patients with aortic dissection and aortic aneurysm. TGF-Β1, TΒRI, and Smad2/3 mainly showed a cytoplasmic immunoreactivity in the aortic media, Smad4 immunoreactivity was predominantly located in the cytoplasm and/or the nucleus of the aortic media, and Smad7 immunoreactivity was present in the nucleus of the aortic media and intima. The TGF-Β1 signalling pathway proteins were similarly expressed in the aorta of aortic dissection and aortic aneurysm patients, while they were less pronounced in the aorta of coronary artery disease patients, and weak or negative in the aorta of healthy control individuals.
Conclusions: These observations support the notion that there is an association between the TGF-Β1/Smad pathway and the pathological events of the aorta. Dysregulation of the TGF-Β1/Smad pathway may predispose the pathologenesis of aortic disorders.
Get Citation

Keywords

aorta; immunohistochemistry; Smad proteins; transforming growth factor-beta

About this article
Title

Transforming growth factor beta1/Smad signalling pathway of aortic disorders: histopathological and immunohistochemical studies

Journal

Folia Morphologica

Issue

Vol 71, No 1 (2012)

Pages

31-38

Published online

2012-04-19

Bibliographic record

Folia Morphol 2012;71(1):31-38.

Keywords

aorta
immunohistochemistry
Smad proteins
transforming growth factor-beta

Authors

S.-M. Yuan

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By  "Via Medica sp. z o.o." sp.k., Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl